ImmuCell Corp
NASDAQ:ICCC
ImmuCell Corp
NASDAQ:ICCC
Price:
6.53
USD
1.4%
Market Closed
Market Cap:
$59.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
ImmuCell Corp
NASDAQ:ICCC
|
US |
|
Burgundy Diamond Mines Ltd
ASX:BDM
|
AU |
|
Metropolitan Bank and Trust Co
XPHS:MBT
|
PH |
|
F
|
Fox E-Mobility AG
XBER:CT4
|
DE |
|
B
|
BP Plastics Holding Bhd
KLSE:BPPLAS
|
MY |
|
Oncolytics Biotech Inc
TSX:ONC
|
CA |
|
Dream Impact Trust
TSX:MPCT.UN
|
CA |
|
Lands End Inc
NASDAQ:LE
|
US |
|
T
|
THC Farmaceuticals Inc
OTC:CBDG
|
US |
|
Definity Financial Corp
TSX:DFY
|
CA |
|
Amdocs Ltd
NASDAQ:DOX
|
US |
|
K
|
Kongsberg Gruppen ASA
OSE:KOG
|
NO |
Multiples-Based Value
The Multiples-Based Value of one
ICCC
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 6.53 USD,
ImmuCell Corp
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ICCC Multiples-Based Value
LOCKED
Multiples Across Competitors
ICCC Competitors Multiples
ImmuCell Corp Competitors
ImmuCell Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
ImmuCell Corp
NASDAQ:ICCC
|
59.1m USD | 2.1 | -56.8 | 14.5 | 38.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
373.2B USD | 6.1 | 89.2 | 14.8 | 20.5 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.4B USD | 6.2 | -96.2 | 951.3 | -107.4 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD | 5.2 | 24.7 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.9B USD | 5.8 | 20 | 12.5 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.2B USD | 9.6 | 29.2 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80B USD | 5.6 | 17.8 | 13.2 | 15.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69.6B AUD | 3.2 | 34.9 | 11.5 | 14.4 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
